Biocardia Stock Earnings Per Share
BioCardia fundamentals help investors to digest information that contributes to BioCardia's financial success or failures. It also enables traders to predict the movement of BioCardia Stock. The fundamental analysis module provides a way to measure BioCardia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioCardia stock.
BioCardia |
BioCardia Company Earnings Per Share Analysis
BioCardia's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current BioCardia Earnings Per Share | (3.20) X |
Most of BioCardia's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCardia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, BioCardia has an Earnings Per Share of -3.2 times. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The earnings per share for all United States stocks is notably higher than that of the company.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
BioCardia Fundamentals
| Return On Equity | -7.04 | |||
| Return On Asset | -1.33 | |||
| Operating Margin | (41.36) % | |||
| Number Of Shares Shorted | 4.26 K | |||
| Revenue | 477 K | |||
| EBITDA | (11.23 M) | |||
| Net Income | (11.57 M) | |||
| Total Debt | 1.31 M | |||
| Book Value Per Share | (1.27) X | |||
| Cash Flow From Operations | (9.97 M) | |||
| Earnings Per Share | (3.20) X | |||
| Number Of Employees | 16 | |||
| Beta | 1.37 | |||
| Total Asset | 2.99 M | |||
| Retained Earnings | (152.18 M) | |||
| Working Capital | (2.15 M) | |||
| Net Asset | 2.99 M |
About BioCardia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioCardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioCardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioCardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |